NIH interim director comes from its research ranks but is known for questioning Covid-19 vaccine mandates
Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory viruses, has been named acting director of the nearly $50 billion agency.
Top NIH official during COVID-19 — who admitted agency funded gain-of-function research in China — resigns
Dr. Lawrence A. Tabak, 73, has abruptly resigned from his post as acting director of the National Institutes of Health (NIH).
China’s denial of coronavirus tinkering at Wuhan lab misleading
Although definitions of gain-of-function differ, investigative reports leave no question researchers manipulated ...
DOGE scraps Fauci museum exhibit as part of $182M in cuts
The Department of Health and Human Services (HHS) canceled more than $180 million in contracts over 48 hours, including a ...
Revenge of the Covid Conspiracy Theorists
After years of GOP attacks on US health agencies, Trump appointees are poised to bring Covid-19 conspiracies to their ...
CDC layoffs strike deeply at its ability to respond to current flu, norovirus and measles outbreaks
Trump administration has taken actions to dismantle established public health infrastructure as part of its second-term ...
FDA Greenlights U.S. Clinical Trial for New Nasal COVID-19 Vaccine
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
Advances in vaccine technology and the road ahead
Explore the evolution of vaccine technology from Jenner to mRNA, highlighting India's role in COVID-19 vaccine development.